1. Pharmacological properties of GR38032F, a novel antagonist at 5-HT3 receptors;Butler;Br. J. Pharmacol.,1988
2. Haberer, L.J., Yin, Y., Palmer, J.L., Kersey, K.E., Depee, S.P., 1997. Pharmacodynamic equivalence of 4 mg ondansetron IV and 4 mg ondansetron IM in the ipecac-induced emesis model. 99th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics, p. 170.
3. Muscarinic activation of ionic currents measured by a new whole-cell recording method;Horn;J. Gen. Physiol.,1988
4. Toward a structural basis for the function of nicotinic acetylcholine receptors and their cousins;Karlin;Neuron,1995
5. Krnjević, K., 1983. GABA-mediated inhibitory mechanisms in relation to epileptic discharges. In: Jasper, H.H., van Gelder, N.M. (Eds.), Basic Mechanisms of Neuronal Hyperexcitability. Alan R. Liss, New York, NY, pp. 249–280.